Storage conditions：Short-term storage at 2~8℃, long-term storage at -20 ~ -80℃

Introduction/Overview

Aloe plants have long attracted significant attention from the scientific community due to their abundant bioactive components and broad medicinal value. Aloenin B, a natural product extracted from the leaves and roots of Aloe hijazensis, has recently become a research hotspot due to its potential antitumor activity. Aloe Ning B has a large molecular weight and complex structure, possessing multiple biological functions, especially showing significant role in regulating tumor-related signaling pathways. This article will systematically review the chemical structure, physicochemical properties, plant origin, and extraction methods of Aloe Vera Ning B, delve into its pharmacological activity and mechanism of action, evaluate its druggability and pharmacokinetic characteristics, and anticipate its clinical application potential, aiming to provide theoretical basis and reference for research and development in related fields.

Chemical structure and physicochemical properties

Aloe Ning B (CAS No.: 106533-41-9) is a natural compound with a complex glycosidic structure, with a molecular weight of 718.6610 and a LogP value of 0.2422, indicating strong hydrophilicity. Its topological pole surface area (TPSA) reaches as high as 264.5, indicating that the molecule contains a high number of polar groups, which may affect its cell membrane permeability and bioavailability. A water solubility of 1.0691 means the compound has good solubility in water, which is of positive significance for the preparation of oral and injectable formulations. The blood-brain barrier has low permeability, suggesting its limited distribution in the central nervous system. The hERG channel inhibition test was negative, indicating a low risk of cardiotoxicity. The Ames-induced mutagenic test result was 0.0, indicating that this compound poses no significant genotoxicity risk.

Chemically, aloe vera-nin B belongs to anthraquinone derivatives, containing multiple hydroxyl and glycosidic groups. These structural features give it excellent bioactivity and ability to bind to protein targets. Its complex polysaccharide chain structure not only increases molecular polarity but may also affect its metabolic stability and pharmacokinetic characteristics.

Plant Origins and Extraction Methods

Aloe Ning B was originally isolated from the leaves and roots of Aloe hijazensis. Aloe hijazensis is an endemic species of the Aloe genus, mainly distributed in specific regions of the Arabian Peninsula. Due to its unique physiological and ecological adaptations, this plant accumulates abundant secondary metabolites, especially anthraquinone compounds.

During extraction, organic solvents such as methanol or ethanol are typically used to extract dried leaves and roots. After concentration, the extract is separated and purified using various chromatography techniques (such as silica gel column chromatography and reversed-phase high-performance liquid chromatography (RP-HPLC)). Aloe Ning B with higher purity can be identified by mass spectrometry (MS), nuclear magnetic resonance (NMR), and infrared spectroscopy (IR) for structural identification. In recent years, emerging technologies such as supercritical fluid extraction and microwave-assisted extraction have also been applied to improve extraction efficiency and purity.

Pharmacological activity research

Research on the pharmacological activity of Aloe Vera Ning B mainly focuses on its antitumor effects. Multiple in vitro cell experiments and in vivo animal model studies have shown that aloe vitamin B can significantly inhibit the proliferation of various tumor cells, induce apoptosis, and suppress tumor metastasis.

In vitro experiments, aloe vitamin B has shown dose-dependent cytotoxic effects on various tumor cell lines (such as breast cancer, lung cancer, liver cancer, and colorectal cancer cells). Its induced apoptosis mechanism involves activation of mitochondrial pathways and death receptor pathways, accompanied by activation of the caspase enzyme family. Aloe Ning B can also inhibit tumor cell migration and invasion, reduce matrix metalloproteinase (MMP) activity, and block matrix degradation in the tumor microenvironment.

Additionally, Aloe Ning B demonstrates anti-inflammatory and antioxidant potential, which indirectly support its anti-tumor activity. Some studies have also found that it regulates tumor-related signaling pathways, suggesting its multi-target action characteristics.

Mechanism of action and molecular targets

The antitumor mechanisms of Aloe Ning B are complex and diverse, mainly achieved by regulating several key molecular targets. Known targets include MCL1, BCL2, STAT3, MMP2, TOP1, HIF1A, TOP2A, MAPK1, ESR1, and CYP19A1.

• MCL1 and BCL2: As anti-apoptotic proteins, MCL1 and BCL2 play key roles in tumor cell survival. Aloe Ning B can downregulate the expression of these two proteins, promoting tumor cell apoptosis.
• STAT3: The STAT3 signaling pathway plays an important role in the development and development of various tumors. Aloe Ning B inhibits STAT3 phosphorylation and nuclear translocation, blocking its transcriptional activity, and suppresses tumor cell proliferation and immune escape.
• MMP2: MMP2 is involved in the degradation and metastasis of the tumor cell stroma. Aloe Ning B significantly reduces the expression and activity of MMP2, inhibiting tumor invasion.
• TOP1 and TOP2A: These two topoisomerases are key enzymes for DNA replication and transcription. Aloe Vera B blocks DNA metabolism in tumor cells by inhibiting TOP1 and TOP2A activities, leading to cell cycle arrest and apoptosis.
• HIF1A: Hypoxia-inducing factor 1α promotes angiogenesis and metabolic reprogramming in the tumor hypoxic microenvironment. Aloe Ning B inhibits HIF1A expression, helping to suppress adaptive tumor growth.
• MAPK1: As an important member of the MAPK signaling pathway, MAPK1 regulates cell proliferation and differentiation. Aloe Ning B can regulate the activity of MAPK1 and influence the growth dynamics of tumor cells.
• ESR1 and CYP19A1: ESR1 encodes estrogen receptor α CYP19A1 aromatase, both of which play significant roles in hormone-dependent tumors such as breast cancer. Aloe Ning B's regulation of these two targets suggests its potential in hormone-related tumor therapy.

In summary, Aloe Vera Ning B exerts its anti-tumor effects through multi-target and multi-pathway synergistic effects, demonstrating the unique multi-target pharmacological advantages of natural products.

Druggability evaluation and pharmacokinetics

Druggability evaluation of Aloe Vera Ning B shows good safety and potential clinical value. Its LogP is 0.2422, indicating moderate molecular hydrophilicity, which is beneficial for distribution and absorption in the body. Although a higher TPSA (264.5) may limit its cell membrane permeability, good water solubility (1.0691) aids formulation development and in vivo dissolution.

The low permeability of the blood-brain barrier suggests it is difficult to enter the central nervous system and reduces the risk of central nervous system toxicity. hERG channel inhibition is negative, reducing the risk of cardiac toxicity such as arrhythmias. A negative Ames test indicates no significant mutagenicity and a relatively high safety profile.

Currently, pharmacokinetic studies on Aloe Ning B are limited. Preliminary data suggest its oral bioavailability is limited, possibly due to its large molecular weight and strong polarity. The metabolic pathway has not been fully elucidated, but it is presumed to be mainly metabolized through hepatic enzyme systems, involving members of the CYP450 family. In the future, systematic pharmacokinetic and toxicological studies are needed to optimize dosing regimens and dosage form design.

Prospects and outlooks for clinical applications

As a multi-target antitumor natural product, Aloe Ning B has broad clinical application prospects. It demonstrates unique advantages in regulating tumor cell apoptosis, inhibiting tumor metastasis, and modulating the tumor microenvironment, making it especially suitable for adjuvant therapy of various solid tumors.

Future research should focus on the following aspects:

1. Preclinical safety and efficacy verification: Systematic animal models and toxicological studies are conducted to clarify safe dose ranges and potential toxic side effects.
2. Pharmacokinetic optimization: Enhancing bioavailability and targeting through structural modification, nanocarriers, and other technologies.
3. Combination therapy strategy: Explore the synergistic effects of Aloe Ning B with existing chemotherapy, targeted, and immunotherapy drugs to enhance treatment outcomes.
4. In-depth mechanistic research: Using multi-omics techniques to analyze its action network to discover more potential targets and biomarkers.
5. Clinical trial design: Based on sufficient preclinical data, conduct early clinical trials to evaluate safety and preliminary efficacy.

With advances in natural product pharmacology and modern drug development technologies, aloe venin B is expected to become an important candidate for novel anti-tumor drugs.

Conclusion

Aloe Ning B, a natural product derived from Aloe hijazensis, demonstrates promising pharmaceutical potential due to its unique chemical structure and multi-target antitumor activity. Its mechanisms in regulating tumor-related signaling pathways, inducing apoptosis, and inhibiting tumor metastasis are becoming increasingly clear, providing new ideas for anti-tumor drug development. Although there are still certain challenges in pharmacokinetics and clinical applications, through optimization of modern medicinal chemistry and formulation methods, Aloe Ning B is expected to achieve translation from laboratory to clinical practice. Future in-depth research will further reveal its pharmacological mechanisms and promote its widespread application in tumor treatment.